ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Roche’s Tecentriq gets FDA priority review to treat small cell lung cancer
December 10, 2018The US Food and Drug Administration (FDA) has granted priority review for Roche’s Tecentriq (atezolizumab) in combination with chemotherapy for treating extensive-stage small cell lung cancer (ES – SCLC)..... -
Roche's marketing application for Tecentriq in small cell lung cancer gets FDA priority review
December 05, 2018Roche said Wednesday that the FDA granted priority review to a marketing application seeking approval of Tecentriq (atezolizumab), in combination with chemotherapy, for the initial treatment of people with extensive-stage small cell lung cancer (SCLC). Th
Pharma Sources Insight January 2025
